Previous 10 | Next 10 |
SAN DIEGO , May 26, 2020 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it will host an investor and analyst video webcast event on Tuesday, June 2 nd , 2020 at 8:00 A...
SAN DIEGO and TOKYO , May 14, 2020 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medica...
LUGANO, Switzerland and SAN DIEGO , May 13, 2020 /PRNewswire/ -- Helsinn Group, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, and MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing potential ne...
SAN DIEGO and TOKYO , May 13, 2020 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing potential new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating in...
MEI Pharma (NASDAQ: MEIP ): Q3 GAAP EPS of -$0.04 beats by $0.10 . Revenue of $1.24M (-0.8% Y/Y) misses by $0.48M . Press Release More news on: MEI Pharma, Inc., Earnings news and commentary, Healthcare stocks news,
SAN DIEGO , May 7, 2020 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for its third quarter ended March 31, 2020 and highlighted recent corporate progress. "Entering ou...
It has been quite some time since my last stock recommendation. However, I have continued to be on the lookout for small-cap biotech stocks that are dramatically undervalued. With the pandemic leaving a lot of uncertainty in the markets, I have been looking not only for small-cap stocks with a...
SAN DIEGO , April 14, 2020 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing potential new therapies for cancer, today announced the appointment of Cheryl L. Cohen to its board of directors. "MEI has done a wonderful job build...
Gainers: NeuroMetrix (NASDAQ: NURO ) +147% . More news on: NeuroMetrix, Inc., Sonnet BioTherapeutics Holdings, Inc., Neovasc Inc., Stocks on the move, , Read more ...
Sonnet BioTherapeutics Holdings (NASDAQ: SONN ) +100% . More news on: Sonnet BioTherapeutics Holdings, Inc., MEI Pharma, Inc., NantKwest, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
-- Ongoing Phase 1 Study Evaluating Voruciclib Plus Venetoclax Demonstrates Anti-leukemic Activity, Including Complete Responses, Anticipated Decreases in Mcl-1 and No Overlapping Toxicity in Heavily Pretreated R/R AML Patients -- -- Board of Directors Unanimously Aligned on Prioritizatio...
– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital, Prioritizing Measured Investment, Extending Operational Runway – MEI Pharma, Inc. ...